Literature DB >> 20938900

Downregulation of FGFRL1 contributes to the development of the diaphragmatic defect in the nitrofen model of congenital diaphragmatic hernia.

J Dingemann1, T Doi, E M Ruttenstock, P Puri.   

Abstract

INTRODUCTION: The nitrofen model of Congenital Diaphragmatic Hernia (CDH) displays a diaphragmatic defect of the Bochdalek-type and has been widely used to investigate the pathogenesis of CDH. However, the exact pathomechanism of the diaphragmatic defect is still poorly understood. Fibroblast growth factor (FGF) receptor-like 1 (FGFRL1), a member of the FGF receptor family, plays a key role in physiological diaphragmatic development. FGFRL1 is expressed in the fetal diaphragm at low levels in early gestation and its expression steadily increases, becoming most pronounced in later gestational stages. It has been reported that FGFRL1 homozygous null mice have thin, partially amuscular diaphragms and die at birth due to respiratory failure. The aim of this study was to investigate the hypothesis that FGFRL1 gene expression in the diaphragm is downregulated during the later gestational stages in the nitrofen CDH model.
MATERIAL AND METHODS: Timed pregnant rats were exposed to either olive oil or 100 mg nitrofen on day 9 of gestation (D9). Cesarean section was performed on D18 or D21. Fetal diaphragms (n=40) were micro-dissected and divided into CDH group and controls. Total RNA was extracted from the diaphragms and the mRNA levels of FGFRL1 were determined using real-time PCR. Immunohistochemistry was performed to evaluate diaphragmatic protein expression of FGFRL1. Student's t-test and Mann-Whitney test were used, where appropriate. Statistical significance was considered for p<0.05.
RESULTS: Relative mRNA expression levels of FGFRL1 were significantly decreased in the CDH group compared to controls on D18 (3.63 ± 1.65 vs. 6.04 ± 3.12, p<0.05) and D21 (1.36 ± 1.01 vs. 2.57 ± 1.34, p<0.05). Immunoreactivity of FGFRL1 was markedly decreased in the diaphragms of the CDH group compared to controls on D18 and D21.
CONCLUSION: Our data provide strong evidence that downregulation of the FGFRL1 gene during the late stages of gestation may contribute to the development of the diaphragmatic defect in nitrofen-induced CDH. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938900     DOI: 10.1055/s-0030-1262853

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  6 in total

1.  Expression of the Wilm's tumor gene WT1 during diaphragmatic development in the nitrofen model for congenital diaphragmatic hernia.

Authors:  Jens Dingemann; Takashi Doi; Elke Ruttenstock; Prem Puri
Journal:  Pediatr Surg Int       Date:  2011-02       Impact factor: 1.827

2.  Prioritization of Candidate Genes for Congenital Diaphragmatic Hernia in a Critical Region on Chromosome 4p16 using a Machine-Learning Algorithm.

Authors:  Danielle A Callaway; Ian M Campbell; Samantha R Stover; Andres Hernandez-Garcia; Shalini N Jhangiani; Jaya Punetha; Ingrid S Paine; Jennifer E Posey; Donna Muzny; Kevin P Lally; James R Lupski; Chad A Shaw; Caraciolo J Fernandes; Daryl A Scott
Journal:  J Pediatr Genet       Date:  2018-05-30

3.  The role of primary myogenic regulatory factors in the developing diaphragmatic muscle in the nitrofen-induced diaphragmatic hernia.

Authors:  Jens Dingemann; Takashi Doi; Elke Ruttenstock; Prem Puri
Journal:  Pediatr Surg Int       Date:  2011-06       Impact factor: 1.827

4.  Evidence that FGFRL1 contributes to congenital diaphragmatic hernia development in humans.

Authors:  Yoel Gofin; Laura Palmer Mackay; Keren Machol; Sundeep Keswani; Lorraine Potocki; Eleonora Di Gregorio; Valeria Giorgia Naretto; Alfredo Brusco; Andres Hernandez-Garcia; Daryl A Scott
Journal:  Am J Med Genet A       Date:  2021-01-14       Impact factor: 2.802

Review 5.  Congenital diaphragmatic hernia.

Authors:  Juan A Tovar
Journal:  Orphanet J Rare Dis       Date:  2012-01-03       Impact factor: 4.123

6.  Targeted disruption of the intracellular domain of receptor FgfrL1 in mice.

Authors:  Gilles Bluteau; Lei Zhuang; Ruth Amann; Beat Trueb
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.